Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeutics
S Srivastava, A Mohanty, A Nam, S Singhal… - Seminars in cancer …, 2022 - Elsevier
Lung cancer persists to contribute to one-quarter of cancer-associated deaths. Among the
different histologies, non-small cell lung cancer (NSCLC) alone accounts for 85% of the …
different histologies, non-small cell lung cancer (NSCLC) alone accounts for 85% of the …
Survivin as a prognostic/predictive marker and molecular target in cancer therapy
F Rodel, T Sprenger, B Kaina, T Liersch… - Current medicinal …, 2012 - ingentaconnect.com
Evasion from apoptotic cell death is reported to be a pivotal mechanism by which tumor cells
acquire resistance to therapeutic treatment. Targeting the apoptotic pathways may constitute …
acquire resistance to therapeutic treatment. Targeting the apoptotic pathways may constitute …
Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer
J Jackute, M Zemaitis, D Pranys, B Sitkauskiene… - BMC immunology, 2018 - Springer
Background Non-small cell lung cancer (NSCLC) remains the most common cause of
cancer related death worldwide. Tumor-infiltrating macrophages are believed to play an …
cancer related death worldwide. Tumor-infiltrating macrophages are believed to play an …
Chemotherapy enhances metastasis formation via VEGFR-1–expressing endothelial cells
LGM Daenen, JML Roodhart, M van Amersfoort… - Cancer research, 2011 - AACR
Recent studies suggest that chemotherapy, in addition to its cytotoxic effects on tumor cells,
can induce a cascade of host events to support tumor growth and spread. Here, we used an …
can induce a cascade of host events to support tumor growth and spread. Here, we used an …
Surface plasmon resonance immunosensor for label-free detection of BIRC5 biomarker in spontaneously occurring canine mammary tumours
We report detection of Baculoviral inhibitor of apoptosis repeat containing-5 (BIRC5) protein
biomarker in dog serum by label-free surface plasmon resonance (SPR) immunosensor …
biomarker in dog serum by label-free surface plasmon resonance (SPR) immunosensor …
Survivin signaling in clinical oncology: a multifaceted dragon
JR Kanwar, SK Kamalapuram… - Medicinal research …, 2013 - Wiley Online Library
Survivin is an inhibitor of apoptosis protein (IAP) family member preferentially expressed in a
myriad of clinical cancers. The complex functional mechanism and regulatory roles of …
myriad of clinical cancers. The complex functional mechanism and regulatory roles of …
Serum concentrations of cytokines and lung cancer survival in African Americans and Caucasians
L Enewold, LE Mechanic, ED Bowman, YL Zheng… - … Biomarkers & Prevention, 2009 - AACR
Accumulating evidence suggests a role for inflammation in the development and
progression of cancer. Our group recently identified a cytokine gene signature in lung tissue …
progression of cancer. Our group recently identified a cytokine gene signature in lung tissue …
Antitumor and immunomodulatory effects of a water-soluble polysaccharide from Lilii Bulbus in mice
X Sun, RL Gao, YK Xiong, QC Huang, M Xu - Carbohydrate polymers, 2014 - Elsevier
Lilii Bulbus is a popular folk medicine in the worldwide and has attracted great attention due
to its bioactivity against respiratory system diseases (include lung cancers). This study was …
to its bioactivity against respiratory system diseases (include lung cancers). This study was …
Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas
We previously identified a chemotherapy-induced paracrine inflammatory loop that
paradoxically mitigates the anti-tumor effect of chemotherapy and triggers metastatic …
paradoxically mitigates the anti-tumor effect of chemotherapy and triggers metastatic …
Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer
Background Hyaluronan (HA) an important component of the extracellular matrix, has been
linked to tumor progression and drug resistance in several malignancies. However, limited …
linked to tumor progression and drug resistance in several malignancies. However, limited …